Risk factors and familial clustering for fever 7–10 days after the first dose of measles vaccines

作者: Nicola P. Klein , Edwin Lewis , Julia McDonald , Bruce Fireman , Allison Naleway

DOI: 10.1016/J.VACCINE.2017.02.013

关键词:

摘要: Abstract Background Seven to ten days after a first dose of measles-containing vaccine (MCV; i.e., MMR or MMRV), children have elevated fever risk which can be associated with febrile seizures. This study investigated individual and familial factors 7–10 days MCV. Methods Retrospective cohort among who were 2 multivariable logistic regression analyses. Results Among 946,806 vaccinated MCV, we identified 7480 (0.8%) MCV-associated visits. Compared without more likely received MMRV than (OR 1.3 95% CI 1.2, 1.5), had medically attended both following previous vaccines 1.1, 1.6) at any other time 1.7 1.6, 1.8), least 1 prior seizure 2.2 1.7, 2.7), >3 medical visits within the 6 months before MCV 1.8). In families multiple MCV-immunized children, adjusting for healthcare seeking behavior care fever, those whose siblings also 3.5 2.5, 4.8). Discussion Children medically-attended fevers seizures during year life increased measles vaccine. After propensity seek care, still clustered families, suggesting possible genetic basis susceptibility developing due vaccines.

参考文章(40)
Kristine K. Macartney, Heather F. Gidding, Lieu Trinh, Han Wang, Jocelynne McRae, Nigel Crawford, Michael Gold, Anne Kynaston, Christopher Blyth, Zurynski Yvonne, Elizabeth Elliott, Robert Booy, Jim Buttery, Helen Marshall, Michael Nissen, Peter Richmond, Peter B. McInytre, Nicholas Wood, Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine. ,vol. 33, pp. 1412- 1417 ,(2015) , 10.1016/J.VACCINE.2014.10.071
Natalie Gavrielov-Yusim, Moshe Hoshen, Shepherd Roee Singer, Lily Neumann, Ran D. Balicer, The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children. Vaccine. ,vol. 32, pp. 4954- 4959 ,(2014) , 10.1016/J.VACCINE.2014.07.024
Kumanan Wilson, Steven Hawken, Jeffrey C. Kwong, Shelley Deeks, Natasha S. Crowcroft, Carl Van Walraven, Beth K. Potter, Pranesh Chakraborty, Jennifer Keelan, Michael Pluscauskas, Doug Manuel, Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis PLoS ONE. ,vol. 6, pp. e27897- ,(2011) , 10.1371/JOURNAL.PONE.0027897
Holly D. Clifford, Stephanie T. Yerkovich, Siew-Kim Khoo, Guicheng Zhang, John Upham, Peter N. Le Souëf, Peter Richmond, Catherine M. Hayden, TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants. Human Immunology. ,vol. 73, pp. 677- 685 ,(2012) , 10.1016/J.HUMIMM.2012.03.004
P Farrington, M Rush, E Miller, S Pugh, A Colville, A Flower, J Nash, P Morgan-Capner, A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines The Lancet. ,vol. 345, pp. 567- 569 ,(1995) , 10.1016/S0140-6736(95)90471-9
N. P. Klein, E. Lewis, B. Fireman, S. J. Hambidge, A. Naleway, J. C. Nelson, E. A. Belongia, W. K. Yih, J. D. Nordin, R. C. Hechter, E. Weintraub, R. Baxter, Safety of Measles-Containing Vaccines in 1-Year-Old Children Pediatrics. ,vol. 135, pp. 321- ,(2015) , 10.1542/PEDS.2014-1822
William E Barlow, Robert L Davis, John W Glasser, Phillip H Rhodes, Robert S Thompson, John P Mullooly, Steven B Black, Henry R Shinefield, Joel I Ward, S Michael Marcy, Frank DeStefano, Virginia Immanuel, John A Pearson, Constance M Vadheim, Viviana Rebolledo, Dimitri Christakis, Patti J Benson, Ned Lewis, Robert T Chen, None, The Risk of Seizures After Receipt of Whole-Cell Pertussis or Measles, Mumps, and Rubella Vaccine The New England Journal of Medicine. ,vol. 345, pp. 656- 661 ,(2001) , 10.1056/NEJMOA003077
M. Hirayama, Measles Vaccines Used in Japan Clinical Infectious Diseases. ,vol. 5, pp. 495- 503 ,(1983) , 10.1093/CLINIDS/5.3.495
Sarah E Williams, What are the factors that contribute to parental vaccine-hesitancy and what can we do about it? Human Vaccines & Immunotherapeutics. ,vol. 10, pp. 2584- 2596 ,(2014) , 10.4161/HV.28596
S. J. Hambidge, S. R. Newcomer, K. J. Narwaney, J. M. Glanz, M. F. Daley, S. Xu, J. A. Shoup, A. Rowhani-Rahbar, N. P. Klein, G. M. Lee, J. C. Nelson, M. Lugg, A. L. Naleway, J. D. Nordin, E. Weintraub, F. DeStefano, Timely Versus Delayed Early Childhood Vaccination and Seizures Pediatrics. ,vol. 133, ,(2014) , 10.1542/PEDS.2013-3429